Please login to the form below

Not currently logged in
Email:
Password:

Edelman extends PR contract with Leo Pharma

Will continue to work together in Germany
edelman

Edelman's Frankfurt office sees its contract with LEO Pharma renewed following a successful year.

The renewed contract will involve Edelman having responsibility for the strategic planning and implementation of trade activities in the field of blood coagulation disorders in Germany, said LEO Pharma.

“Last year Edelman successfully supported us with their health industry expertise, which was essential in the communications process during our first benefit assessment in the area of dermatology,” said LEO Pharma spokesman Thomas Schick.

“We are happy to work with them now in the thrombosis business division”.

With this renewed contract, Edelman is continuing to expand its portfolio of clients in the field of classical technical communication, the agency said.

“With LEO, we're now working on a couple of topics – not campaigns,” Martin Flörkemeier, managing director of Edelman in Germany, told PMLiVE.

“Knowing that they've just awarded us this new piece of work because of their high satisfaction with our strategic competence, service quality and exactly the right team match, we would hope that this partnership will remain healthy and potentially grow further in the future.”

Founded in 1908, LEO Pharma provides medical solutions in more than 100 countries. It is headquartered in Denmark, owned by the LEO Foundation and employs 4,800 staff worldwide.

6th March 2014

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....

Infographics